🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are honored to announce that Erkki Ruoslahti has been named a #LaskerLaureate. The #LaskerAward is the most prestigious American award for biomedical research, and has been called the "American Nobel" Lasker Foundation #Lasker2022 #LaskerAward bit.ly/ruoslahtilaske…

ASCO 2022 on the Multicenter Phase Ib US Trial of Salvage CT041 CLDN18.2-Specific CAR T-Cell Therapy for Advanced Gastric and Pancreatic Adenocarcinoma | VuMedi vumedi.com/video/asco-202… via @vumedi

GI Cancers Series Part 3: Immunotherapy and Targeted Therapy in GI Cancers CURE® 12/6/22, 6:00 PM GMT -4 summer John L. Marshall Gregory Botta Tanios Bekaii-Saab, MD Martha Raymond docmeetings.com/events/1908fa1…

onlinelibrary.wiley.com/doi/10.1002/ca…

Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancers. See our JCO Precision Oncology manuscript out today: ascopubs.org/doi/full/10.12… #ctDNA

👇🏾🆕 JCO Precision Oncology Delighted to be a part of this important project - one of the largest datasets providing in-depth insights & analyses into #ctDNA🩸🧬 in stomach & esophageal cancers. #STCSM #ESOCSM ➡️Sets the foundation for #MRD-driven📚. OncoAlert 📌ascopubs.org/doi/full/10.12…

ascopubs.org/doi/10.1200/PO…

🆕Just published🗞️ One of the 1st insights on🩸#ctDNA in patients with #AnalCancer. Of value in a number of ways & clinical settings with how the field is evolving including use of #immunotherapy➕deeper insights from sequencing🧬. OncoAlert The Oncologist academic.oup.com/oncolo/advance…

🌟HOT OFF THE PRESS🌟FOR ASCO #GI23! TARGETED THERAPIES🎯WORK in PANCREATIC CANCER‼️ In npj Journals from MCW Cancer Center Razelle Kurzrock, MD & UC San Diego Health Justin Shaya Gregory Botta Jason Sicklick! rdcu.be/c3RwS

Plus chat with GI medical oncologist Gregory Botta from UC San Diego Health Moores Cancer Center and pancreatic cancer survivor Russ Gold Russ Gold PanCAN SD Affiliate Register now! See you there!

Physician-scientist Prof. Maximilian Reichert uses #organoid technology to model #pancreatic cancer in order to develop new treatment strategies. Listen to his talk on 🗓️July 12 at ⏰16:15: go.tum.de/650300 #WeareMIBE TU München Maximilian Reichert Reichert Lab 📷Golddecker

link.springer.com/article/10.100…

Honored to chair this outstanding conference. 💥🔥🌈🎯 Nigel and Deanna Russell at Genome Web did a great job. The speakers were so incredible that people were not looking at their iPhones. Bring together academia, industry, patients to transform precision oncology

Day 1 at #ESMOWest2023 was a blast! 🚀 A special thank you to our fantastic speakers today for sharing their incredible expertise! Mark Lewis, MD, FASCO Gregory Botta Ravi A Madan M.D. marcellorotta Mike Lattanzi Krishna Komanduri, MD, FASTCT Brian Van Tine #MedEd #Oncology #MedTwitter

UCSD Faculty member, Dr. Andy Lowy delivering the MSKCC David Rubenstein Award Lecture in New York City. Prestigious award given annually for impacting the understanding, diagnosis and/t management of pancreatic cancer eradication Congratulations Dr. Lowy!

It’s official! It is my absolute privilege to be named as the Director of the Moores Comprehensive Cancer Center at UCSD Health. I am looking forward to advancing efforts in cancer based on an approach of collaboration and excellence.

Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells | Journal for ImmunoTherapy of Cancer jitc.bmj.com/content/12/2/e…

New #JITC case report: Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells bit.ly/4bvXmuG Gregory Botta Dan Kaufman Ezra Cohen

In ESMO Open led by UC San Diego Health Daisuke Nishizaki, MD Gregory Botta Jason Sicklick Razelle Kurzrock, MD Dartmouth Cancer Center Hirotaka Miyashita, MD,🕶️Viewing the immune checkpoint VISTA‼️ ⬆️VISTA correlates with⬆️BTLA,⬆️TIM-3,⬆️TNFRSF14 &⬇️poorer post-ICI survival in pancreas cancer‼️bit.ly/3x3N0Tq

Our expert team's new publication on the Association of personalized and tumor-informed #ctDNA with patient survival outcomes in #pancreaticcancer academic.oup.com/oncolo/article… UC San Diego Health Moores Cancer Center